BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 28751524)

  • 1. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.
    Wallace JA; O'Connell RM
    Blood; 2017 Sep; 130(11):1290-1301. PubMed ID: 28751524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
    Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
    J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
    Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
    Front Immunol; 2020; 11():582915. PubMed ID: 33519805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
    Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA: an important regulator in acute myeloid leukemia.
    Wang X; Chen H; Bai J; He A
    Cell Biol Int; 2017 Sep; 41(9):936-945. PubMed ID: 28370893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia.
    He C; Luo B; Jiang N; Liang Y; He Y; Zeng J; Liu J; Zheng X
    Leuk Lymphoma; 2019 Feb; 60(2):284-294. PubMed ID: 30187809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
    Zhang C; Bai G; Zhu W; Bai D; Bi G
    Med Sci Monit; 2017 Oct; 23():4705-4714. PubMed ID: 28965123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155 expression and function in AML: An evolving paradigm.
    Narayan N; Bracken CP; Ekert PG
    Exp Hematol; 2018 Jun; 62():1-6. PubMed ID: 29601851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-181b targets MLK2 in HL-60 cells.
    Chen H; Chen Q; Fang M; Mi Y
    Sci China Life Sci; 2010 Jan; 53(1):101-106. PubMed ID: 20596961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia.
    Ye J; Luo D; Yu J; Zhu S
    Hematology; 2019 Dec; 24(1):487-491. PubMed ID: 31210592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.
    Lin XC; Xu Y; Sun GP; Wen JL; Li N; Zhang YM; Yang ZG; Zhang HT; Dai Y
    Int J Oncol; 2016 Jun; 48(6):2367-80. PubMed ID: 27082628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155.
    Tian WL; Jiang ZX; Wang F; Guo R; Tang P; Huang YM; Sun L
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1130-5. PubMed ID: 27530922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aryl hydrocarbon receptor pathway: a key component of the microRNA-mediated AML signalisome.
    Rager JE; Fry RC
    Int J Environ Res Public Health; 2012 May; 9(5):1939-53. PubMed ID: 22754483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth characterization of the microRNA transcriptome in a leukemia progression model.
    Kuchenbauer F; Morin RD; Argiropoulos B; Petriv OI; Griffith M; Heuser M; Yung E; Piper J; Delaney A; Prabhu AL; Zhao Y; McDonald H; Zeng T; Hirst M; Hansen CL; Marra MA; Humphries RK
    Genome Res; 2008 Nov; 18(11):1787-97. PubMed ID: 18849523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
    Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: pivotal regulators in acute myeloid leukemia.
    Li M; Cui X; Guan H
    Ann Hematol; 2020 Mar; 99(3):399-412. PubMed ID: 31932900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.